Investigating postmenopausal bleeding for endometrial cancer: Cost-effectiveness of initial diagnostic strategies

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 113, Issue 5, 2006, Pages 502-510

  Clark, T J ^a   Barton, P M ^b   Coomarasamy, A ^a   Gupta, J K ^a   Khan, K S ^a  

^a BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Cost effectiveness; Endometrial biopsy; Hysteranopy; Postmenopausal bleeding

Indexed keywords

ANALYTIC METHOD; CANCER DIAGNOSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; ECHOGRAPHY; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; EVALUATION; FEMALE; HUMAN; HYSTEROSCOPY; OUTCOMES RESEARCH; OUTPATIENT; POSTMENOPAUSE; POSTMENOPAUSE BLEEDING; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY ANALYSIS; VAGINA BLEEDING;

AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANALYSIS OF VARIANCE; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; ENDOMETRIAL NEOPLASMS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PRACTICE GUIDELINES; SENSITIVITY AND SPECIFICITY; UTERINE HEMORRHAGE;

EID: 33645963159     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2006.00914.x     Document Type: Review

References (47)

1. Office for National Statistics. Key Health Statistics from General Practice: Analyses of Morbidity and Treatment Data, Including Time Trends, England and Wales. London National Statistics 1998 www.statistics.gov.uk/downloads/theme_health/Key_Health_Stats_1998.pdf Accessed 14 January 2002.
2. Department of Health. Referral guidelines for suspected cancer. 1999 www.doh.gov.uk/cancer Accessed 27 September 2002.
3. Quinn M Babb P Brock A Kirby L Jones J. Cancer Trends in England and Wales 1950-1999. London Office of National Statistics 2001 www.statistics.gov.uk/downloads/theme_health/cancertrends_5099.pdf Accessed 14 January 2002.
4. Bachmann LM ter Riet G Clark TJ Gupta JK Khan KS. Probability analysis for diagnosis of endometrial hyperplasia and cancer in postmenopausal bleeding: an approach for a rational diagnostic workup. Acta Obstet Gynecol Scand 2003 82 1 6.
5. NHS Executive. National Cancer Guidance Steering Group. Guidance on commissioning cancer services: improving outcomes in gynaecological cancers. 1999 www.doh.gov.uk/cancer/gynaecological.htm Accessed 25 September 2002.
6. Parkrim OM Bray F Ferlay J Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001 94 153 6. Globocan 2000: Cancer Incidence Mapw. Geneva, Switzerland World Health Organisation 2000 www-dep.iarc.fr/globocan/globocan.html
7. Spencer CP Whitehead MI. Endometrial assessment re-visited. Br J Obstet Gynaecol 1999 106 623 32.
8. Scottish Intercollegiate Guidelines Network. Investigation of Post-menopausal Bleeding 1st edn. Edinburgh, UK Scottish Intercollegiate Guidelines Network, Royal College of Physicians 2002 www.sign.ac.uk
9. Clark TJ Voit D Gupta JK Hyde C Song FS Khan KS. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA 2002 288 1610 22.
10. Clark TJ Mann CH Shah N Khan KS Song F Gupta JK. Accuracy of outpatient endometrial biopsy in the diagnosis of endometrial cancer: a systematic quantitative review. BJOG 2002 109 313 21.
11. Dijkhuizen FPHL Mol BWJ Brolmann HAM Heintz APM. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer 2000 89 1765 72.
12. Gupta JK Chien PF Voit D Clark TJ Khan KS. Ultrasonographic endometrial thickness for diagnosing endometrial pathology in women with postmenopausal bleeding: a meta-analysis. Acta Obstet Gynecol Scand 2002 81 799 816.
13. Smith-Bindman R Kerlikowske K Feldstein VA Subak L Scheidler J Segal M et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA 1998 280 1510 17.
14. Tabor A Watt HC Wald NJ. Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding. Obstet Gynecol 2002 99 663 70.
15. Lilford RJ Pauker SG Braunholtz DA Chard J. Decision analysis and the implementation of research findings. BMJ 1998 317 405 9.
16. Elwyn G Edwards A Eccles M Rovner D. Decision analysis in patient care. Lancet 2001 358 571 4.
17. Grimes DA. Diagnostic dilation and curettage: a reappraisal. Am J Obstet Gynecol 1982 142 1 6.
18. Rogerson L Downes E. How do UK gynaecologists manage endometrial carcinoma? A national survey. Eur J Gynaecol Oncol 1998 19 331 2.
19. Clark TJ Bakour SH Gupta JK Khan KS. Evaluation of outpatient hysteroscopy and ultrasonography in the diagnosis of endometrial disease. Obstet Gynecol 2002 99 1001 7.
20. Creasman WT Odicino F Maisonneuve P Beller U Benedet JL Heintz AP et al. Carcinoma of the corpus uteri. J Epidemiol Biostat 2001 6 47 86.
21. Wingo PA Huezo CM Rubin GL Ory HW Peterson HB. The mortality risk associated with hysterectomy. Am J Obstet Gynecol 1985 152 803 8.
22. NHS Centre for Reviews and Dissemination. Management of gynaecological cancers. Eff Health Care Bull 1999 5 1 12 www.york.ac.uk/inst/crd/ Accessed 27 September 2002.
23. Southcott BM. Carcinoma of the endometrium. Drugs 2001 61 1395 405.
24. National Cancer Institute. Endometrial cancer. 2002 www.cancer.gov Accessed 27 September 2002.
25. Martin-Hirsch PL Jarvis G Kitchener H Lilford R. Progestagens for endometrial cancer. Cochrane Database Syst Rev 2000 CD001040.
26. NHS Executive. The New NHS: 1999 Reference Costs. Leeds, UK NHSE, 2000 www.doh.gov.uk/nhsexec/refcosts/refcosts2000.htm Accessed 25 September 2002.
27. Netten A Curtis L. Unit Costs of Health and Social Care (2000). Canterbury, UK Personal Social Services Research Unit, University of Kent 2000 www.ukc.ac.uk/PSSRU/ Accessed 25 September 2002.
28. Gold M Patrick DL Torrance GW Fryback DG Hadborn DC Kamlet MS et al. Identifying and valuing outcomes. In Gold MR Siegel JE Russell LB Weinstein MC editors. Cost-Effectiveness in Health and Medicine. New York Oxford University Press 1996. p. 82 134.
29. Meltzer MI. Introduction to health economics for physicians. Lancet 2001 358 993 8.
30. Palmer S Byford S Raftery J. Economics notes: types of economic evaluation. BMJ 1999 318 1349.
31. Government Actuary's Department. Interim Life Tables 2000-2002 www.gad.gov.uk/Life_Tables/Interim_life_tables.htm Accessed 10 February 2004.
32. Haybittle JL Kingsley-Pillers EM. Long-term survival experience of female patients with genital cancer. Br J Cancer 1988 57 322 5.
33. O'Brien BJ Heyland D Richardson WS Levine M Drummond MF. Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. B. What are the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group. JAMA 1997 277 1802 6.
34. Torgerson DJ Raftery J. Economic notes. Discounting. BMJ 1999 319 914 15.
35. Briggs AH Gray AM. Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess 1999 3 1 134.
36. Raftery J. NICE: faster access to modern treatments? Analysis of guidance on health technologies. BMJ 2001 323 1300 3.
37. Briggs A Gray A. Using cost effectiveness information. BMJ 2000 320 246.
38. Drummond MF Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 1996 313 275 83.
39. Bennett CC Richards DS. Patient acceptance of endovaginal ultrasound. Ultrasound Obstet Gynecol 2000 15 52 5.
40. Siegel JE Weinstein MC Russell LB Gold MR. Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996 276 1339 41.
41. Drummond MF Richardson WS O'Brien BJ Levine M Heyland D. Users' guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 1997 277 1552 7.
42. Feldman S Berkowitz RS Tosteson AN. Cost-effectiveness of strategies to evaluate postmenopausal bleeding. Obstet Gynecol 1993 81 968 75.
43. Hidlebaugh D. A comparison of clinical outcomes and cost of office versus hospital hysteroscopy. J Am Assoc Gynecol Laparosc 1996 4 39 45.
44. Ong S Duffy T Lenehan P Murphy J. Endometrial pipelle biopsy compared to conventional dilatation and curettage. Ir J Med Sci 1997 166 47 9.
45. Weber AM Belinson JL Bradley LD Piedmonte MR. Vaginal ultrasonography versus endometrial biopsy in women with postmenopausal bleeding. Am J Obstet Gynecol 1997 177 924 9.
46. Dijkhuizen FP Mol BW Brolmann HA Heintz AP. Cost-effectiveness of the use of transvaginal sonography in the evaluation of postmenopausal bleeding. Maturitas 2003 45 275 82.
47. Raftery J. Costing in economic evaluation. BMJ 2000 320 1597.